Scope

Aims and Scope: The Journal of Angiotherapy (JoA) is an international, peer-reviewed, open-access journal dedicated to advancing the understanding of angiogenesis—the process of new blood vessel formation and inflammation—and its role in both physiological and pathological conditions. As a multidisciplinary platform, JoA bridges various fields including pharmacology, toxicology, drug discovery, therapeutics, health, and pharmaceutical sciences, offering a comprehensive exploration of the intersection between angiogenesis, inflammation, and therapeutic interventions. JoA serves as a dynamic platform for researchers, clinicians, and scientists to explore the complexities of inflammation, diseases and health interventions.

The journal specializes in topics related to:

• Angiogenesis and Inflammation: Exploring the intricate relationship between angiogenesis and inflammatory processes, particularly in all infectious and metabolic diseases; for example: autoimmune, inflammation-driven diseases, neurodegenerative conditions, cancer, vascular diseases, endothelial cell biology, ocular diseases, neovascularization and associated disorders, etc.
• Therapeutic Discovery: Emphasizing innovative approaches to drug development and the therapeutic potential of natural products, plant extracts, and small molecules in targeting the diseases.

• Inflammation and Disease Mechanisms: The journal emphasizes the critical role of inflammation in the progression of various diseases. Understanding these mechanisms is key to developing innovative therapeutic strategies for diseases.

• Health Interventions: JoA's broad scope encompasses research on health interventions aimed at modulating disease processes. This includes studies on pharmacology, toxicology, drug discovery, therapeutics, clinical study, diagnosis, disease modeling, health technology, clinical trials, physiology, and pharmaceutical sciences, with a focus on translating basic research into clinical applications, suregry and blood.

• Cross-Disciplinary Research: Encouraging contributions from diverse scientific fields such as biochemistry, bioengineering, biotechnology, bioinformatics, biomathematics, biophysics, physiology, immunology, microbiology, neuropharmacology, and more, JoA aims to foster collaboration and knowledge exchange across disciplines with a research into inflammation driven, and metabolic disease and human health and life style issues i.e. obesity, exercise etc.

JoA recognizes the value of interdisciplinary research and encourages submissions that bridge traditional boundaries. The journal invites contributions from a wide range of fields, including but not limited to pharmacology, and: 

• Pharmaceutical Sciences: Exploring novel drug formulations, delivery systems, and therapeutic agents targeting various diseases.
• Biochemistry & Structural Biology: Investigating the molecular and structural aspects of inflammatory factors and their pathways in different diseases.
• Biotechnology & Bioengineering: Applying engineering principles to design innovative solutions for various disease and inflammation-related challenges.
• Bioinformatics & Computational Biology: Utilizing computational tools to model, predict, and analyze various disease inflammatory and vascular disease processes and their impact on health.
• Cell, Molecular & Developmental Biology: Studying the cellular and molecular mechanisms governing angiogenesis, inflammation and its regulation.
• Medicine: Focusing on clinical research that translates angiogenesis science into therapeutic interventions for diseases such as acute, and chronic autoimmune, metabolic, neurodegenerative, inflammatory or any pathogenic conditions.
• Genetics & Genomics: The genetic and epigenetic factors that influence metabolic, auto-immune, angiogenesis and inflammation related pathologies.
• Immunology & Microbiology: Investigating the immune responses and microbial interactions that affect immune systems.
• Neuroscience: Exploring the role of angiogenesis, inflammation in neurological diseases and brain health.
• Plant Sciences & Natural Agents: Examining the potential of natural products and plant extracts in modulating angiogenesis, inflammation and complex metabolic mechanism.
• Chemical Sciences: Synthesis research into the chemistry of angiogenic, inflammatory molecules and any therapeutic agents.
• Zoology & Comparative Physiology: Providing insights into the evolutionary aspects of angiogenesis, inflammation, medicine across different species.

JoA welcomes the submission of original research articles, reviews, data reports, case studies, clinical trials, and brief communications that present significant, novel findings and advance knowledge within the realm of angiogenesis and its related areas.

All accepted manuscripts are published continuously and made freely available online immediately upon publication. This open-access model ensures unrestricted access to research, facilitating widespread dissemination and engagement within the scientific community.

JoA is committed to being a valuable resource for researchers, scientists, and clinicians aiming to expand the boundaries of knowledge in angiogenesis-inflammation health process, auto-immune, metabolic, inflammation-driven and neurodegenerative disease process and its related fields.

Peer-Review Process (please see detials in peer review policy and publishing policies)

The journal is committed to publishing research works by utilizing a rapid, impartial, and rigorous review process. All submitted papers are subjected to strict single-blind peer review by its distinguished international Advisory Board members, as well as by other anonymous international and national reviewers. Submitted manuscripts must not have been published previously in any copyright form (print or electronic/online).

The journal is committed to publishing research works by utilizing a rapid, impartial, and rigorous review process. All submitted papers are subjected to strict single blind peer review by its distinguished international Advisory Board members, as well as by other anonymous international and national reviewers. Submitted manuscripts must not have been published previously in any copyright form (print or electronic/online).

The general criteria for acceptance of a manuscript are:

• advances scientific knowledge;

• advances translational research;

• provides an adequate and relevant literature review;

• utilizes scientifically solid, reliable, and reproducible methodologies;

• derives appropriate and justifiable conclusions based upon the experimental data presented; and

• is written in English and is of the utmost quality and clarity.

JoA will facilitate the author's response to the NIH Public Access Policy.